Try our Advanced Search for more refined results
June 04, 2014
ROCHESTER DRUG CO-OPERATIVE, INC. v. ENDO HEALTH SOLUTIONS INC. et al
Case Number:
2:14-cv-03185
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 06, 2014
Endo, Impax Schemed To Delay Opana Generics, Suit Says
Endo Pharmaceuticals Inc. and Impax Laboratories Inc. were hit with a proposed antitrust class action in Pennsylvania federal court Wednesday alleging Endo paid Impax more than $112 million to delay generic versions of Endo's patented Opana ER painkiller from hitting the market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login